Severe Autoinflammatory Manifestations and Antibody Deficiency Due to Novel Hypermorphic PLCG2 Mutations.

A, Martín-Nalda; C, Fortuny; L, Rey; TD, Bunney; L, Alsina; A, Esteve-Solé; D, Bull; MC, Anton; M, Basagaña; F, Casals; A, Deyá; M, García-Prat; R, Gimeno; M, Juan; H, Martinez-Banaclocha; JJ, Martinez-Garcia; A, Mensa-Vilaró; R, Rabionet; N, Martin-Begue; F, Rudilla; J, Yagüe; X, Estivill; V, García-Patos; RM, Pujol; P, Soler-Palacín; M, Katan; P, Pelegrín; R, Colobran; A, Vicente; JI, Arostegui

doi:10.1007/s10875-020-00794-7

Public

Severe Autoinflammatory Manifestations and Antibody Deficiency Due to Novel Hypermorphic PLCG2 Mutations.

Shared by NobleBlocks on Jul 15, 2020 • 12:00 AM UTC

Authors:

Martín-Nalda A

Fortuny C

Rey L

Abstract

Autoinflammatory diseases (AIDs) were first described as clinical disorders characterized by recurrent episodes of seemingly unprovoked sterile inflammation. In the past few years, the identification of novel AIDs expanded their phenotypes toward more complex clinical pictures associating vasculopat...

Subject

Interleukin-1

Agammaglobulinemia

Autoinflammatory Diseases

Research Assistant

AI chat, annotations, notes & similar papers

Finding related papers...

Discussions

(0)

No comments yet

Be the first to share your thoughts!